imdusiran
-
Warminster Biopharma Firm Ends $285M Licensing Deal with Chinese Company
Warminster-based Arbutus Biopharma has ended a 4-year licensing deal worth up to $285 million with Qilu Pharmaceuticals, a Chinese drugmaker, writes John George for the…
Founding Partners
Advertisement
Affiliate Partners
